British drug-maker AstraZeneca said it will close its research and development unit in Bangalore, India, making more than 150 jobs redundant. The move, as part of an ongoing global restructuring exercise, will also shut down its early stage research on tropical diseases tuberculosis and malaria. The existing research will be moved to its UK facility … Continue reading
The European Commission has today proposed to provide Sweden with €4.3 million from the European Globalisation Adjustment Fund (EGF) to help 700 workers made redundant by the pharmaceutical firm AstraZeneca back to employment. The proposal now goes to the European Parliament and the EU’s Council of Ministers for their approval. EU Commissioner for Employment, Social … Continue reading
After years of flying high, biopharma job growth is running into turbulence, a number of factors have increasingly pushed big pharma into layoffs. Although the picture is bleak now, the industry’s longer-term employment prospects appear brighter. Roche will eliminate 1,000 jobs by the end of 2013 when it shuts down its Nutley, NJ, R&D site. … Continue reading